First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
Stocks · News reference
Allot Reports Q2 2026 Results: Full Earnings Call Transcript
On Wednesday, Allot (NASDAQ:ALLT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
U.S. Cybersecurity Agencies Warn China-Based Cybersecurity Company Enabling Threat Actors To Target Multiple Critical Infrastructure Sectors Worldwide
Shares of cybersecurity-related companies are trading higher. The sector may be experiencing rotational interest from investors as a hedge against continued AI tool deployment, which may yield more demand for more security, or as a haven against weakness in AI-related tech stocks.
Unconfirmed Social Media Reports Suggest The ShinyHunters Hacking Group Claims To Have Breached The FBI, Stating The Attack Is "Not Financially Motivated." The FBI Has Not Yet Commented.